GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Overview Fund Activity
Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

93 hedge funds and large institutions have $457M invested in G1 Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 17 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
–
Holders Change %
0%
% of All Funds
2.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
41
Reduced
17
Closed
14
Calls
$183K
Puts
$178K
Net Calls
+$5K
Net Calls Change
+$6K

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$77M
2
RCM
2
RA Capital Management
Massachusetts
$6.03M
3
VOYA Investment Management
3
VOYA Investment Management
Georgia
$8.03M
4
Bank of America
4
Bank of America
North Carolina
$7.4M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$31.1M

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$0
2
Capital World Investors
2
Capital World Investors
California
$1.4M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$1.41M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$24.7M
5
Capital International Investors
5
Capital International Investors
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$93.1M +$556K +33,481 +0.6%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$77M +$14.4M +866,859 +23%
BlackRock
3
BlackRock
New York
$32.2M -$437K -26,298 -1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$31.1M +$2.93M +176,440 +10%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$24.7M -$3.47M -209,032 -12%
Franklin Resources
6
Franklin Resources
California
$20.5M -$3.32K -200 -0%
State Street
7
State Street
Massachusetts
$20M -$166K -9,978 -0.8%
JPMorgan Chase & Co
8
JPMorgan Chase & Co
New York
$18.6M +$1.48M +89,450 +9%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$18.5M +$455K +27,415 +3%
HA
10
HHLR Advisors
Cayman Islands
$15.8M – – –
BB
11
BB Biotech
Switzerland
$11.2M – – –
VOYA Investment Management
12
VOYA Investment Management
Georgia
$8.03M +$4M +240,942 +99%
Bank of America
13
Bank of America
North Carolina
$7.4M +$3.19M +192,398 +76%
RCM
14
RA Capital Management
Massachusetts
$6.03M +$6.03M +363,051 New
Morgan Stanley
15
Morgan Stanley
New York
$5.91M +$2.48M +149,498 +72%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$5.18M +$551K +33,167 +12%
Northern Trust
17
Northern Trust
Illinois
$4.82M +$141K +8,472 +3%
Citadel Advisors
18
Citadel Advisors
Florida
$4.62M +$1.77M +106,653 +62%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$4.07M +$2.71M +162,989 +199%
RPAM
20
Rhenman & Partners Asset Management
Sweden
$3.52M +$653K +39,349 +23%
Deutsche Bank
21
Deutsche Bank
Germany
$3.02M +$2.23M +134,618 +283%
Millennium Management
22
Millennium Management
New York
$2.53M +$2.3M +138,353 +987%
Charles Schwab
23
Charles Schwab
California
$2.33M +$89.5K +5,391 +4%
UBS AM
24
UBS AM
Illinois
$2.26M +$11.8K +711 +0.5%
Two Sigma Investments
25
Two Sigma Investments
New York
$2.15M +$889K +53,563 +71%
1
2 3 4 5